Issue 12/2016
Content (8 Articles)
Acknowledgement to Referees
Acknowledgement to Referees
Leading Article
Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson’s Disease: Therapeutic Rationale and Current Status
Tara Swart, Michael J. Hurley
Review Article
B Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence
Silke Kinzel, Martin S. Weber
Review Article
Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications
Melinda Liu, Yuan Yu M. Huang, Sylvia Hsu, Joseph S. Kass
Review Article
Pharmacogenetics and Imaging–Pharmacogenetics of Antidepressant Response: Towards Translational Strategies
Tristram A. Lett, Henrik Walter, Eva J. Brandl
Open Access
Review Article
Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review
Rainer Freynhagen, Miroslav Backonja, Stephan Schug, Gavin Lyndon, Bruce Parsons, Stephen Watt, Regina Behar
Original Research Article
Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus in Adults: A Prospective Randomized Controlled Trial in China
Yingying Su, Gang Liu, Fei Tian, Guoping Ren, Mengdi Jiang, Brian Chun, Yunzhou Zhang, Yan Zhang, Hong Ye, Daiquan Gao, Weibi Chen
Original Research Article
The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years
Mark Zimmerman, Carolina Guzman Holst, Heather L. Clark, Matthew Multach, Emily Walsh, Lia K. Rosenstein, Douglas Gazarian